reviewNew England Journal of MedicineMar 4, 2020Closed access

Pituitary-Tumor Endocrinopathies

Cedars-Sinai Medical Center

PubMed
Indexed incrossrefpubmed

Abstract

Pituitary adenomas account for about 15% of intracranial tumors. Clinical manifestations of disease reflect the oversecretion of the involved hormone, most commonly growth hormone, prolactin, corticotropin, or thyrotropin. Diagnosis and management of these disorders are reviewed.

Citation impact

577
total citations
FWCI
44.30
Percentile
100%
References
94
Citations per year

Authors

1

Topics & keywords

Keywords
  • Medicine
  • Prolactin
  • Pituitary tumors
  • Pituitary disorder
  • Growth hormone
  • Pituitary disease
  • Pituitary adenoma
  • Pituitary neoplasm
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.